News
Press Releases & Media
Latest updates from Carvolix and our portfolio companies.
Webinar – Biotech Finances
Press review
Webinar – Biotech Finances
September 30, 2025
L’express – Abivax: From Havana to Nasdaq
Press review
L’express – Abivax: From Havana to Nasdaq
December 18, 2025
Le JDD – Philippe Pouletty, CEO of Truffle Capital “The government must back science and innovation”
Press review
Le JDD – Philippe Pouletty, CEO of Truffle Capital “The government must back science and innovation”
January 18, 2026
Le Figaro – Truffle Capital hopes to create a leader in AI applied to cardiology
Press review
Le Figaro – Truffle Capital hopes to create a leader in AI applied to cardiology
February 2, 2026
La Tribune – Medtech: Carvolix, Truffle Capital’s bet to disrupt interventional cardiology
Press review
La Tribune – Medtech: Carvolix, Truffle Capital’s bet to disrupt interventional cardiology
January 19, 2026
AIX-EN-PROVENCE – The Next Surgical Robotics Powerhouse Plants Its Roots in Aix
Press review
AIX-EN-PROVENCE – The Next Surgical Robotics Powerhouse Plants Its Roots in Aix
February 28, 2026
Invest Securities upgrades Carvolix: “Cardiovascular innovation meets robotics”
Press review
Invest Securities upgrades Carvolix: “Cardiovascular innovation meets robotics”
February 16, 2026
CFNEWS – Three Truffle Capital companies join forces
Press review
CFNEWS – Three Truffle Capital companies join forces
January 5, 2026
BioWorld – Affluent becoming Carvolix after acquisitions
Press review
BioWorld – Affluent becoming Carvolix after acquisitions
January 14, 2026
Carvolix is born and funded
Press Release
Carvolix is born and funded
- Affluent Medical officially becomes CARVOLIX
- Completion of the acquisitions of CARANX MEDICAL and ARTEDRONE
- 10m€ first tranche of financing completed
February 2026